Neuralnauts | Audrey: technical breakdown, key moments and clinical context
Released on 26 August 2026 ('Neuralnauts | Audrey', 1:51), this profile revisits Audrey—the first female participant in the PRIME clinical trial—showing how her daily fluency with Telepathy cursor control has evolved into creating intricate digital artwork and illustrations independently at home.
- Primary record: Official
@neuralinkvideo (R03-DWvWmAY) published on 26 Aug 2026 (duration1:51). - What it shows: Sustained, fine-grained 2D trajectory control suitable for freehand illustration rather than just coarse grid clicking.
- Technical pathway: Motor cortex hand area → N1 Bluetooth telemetry → 2D cursor velocity & pressure/click control → illustration app.
- Evidence boundary: Participant experience profile in PRIME (NCT06429735); individual creative workflow.
Watch the official video record
Official upload from @neuralink (26 Aug 2026, 1:51).
Read verbatim official @neuralink YouTube description & caption provenance
Caption & verification basis: English manual + auto-generated captions (Official video playback, English caption track, official description, and primary Neuralink disclosures).
With Neuralink, Audrey is creating art with her mind. Learn more about Neuralink’s clinical trials: https://neuralink.com/trials/ Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities. This video features voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.
Technical pathway and evidence classification
Motor cortex hand area → N1 Bluetooth telemetry → 2D cursor velocity & pressure/click control → illustration app
Participant experience profile in PRIME (NCT06429735); individual creative workflow.
Timestamped breakdown and key moments
| Timestamp | Segment / event | What happens in the segment |
|---|---|---|
00:00 | Audrey's creative workflow | Shows freehand digital brush strokes controlled entirely via cortical movement intent. |
00:55 | Precision cursor trajectory | Highlights fine path control without physical hand or stylus motion. |
01:25 | Independent daily use | Reflects on regaining creative expression 20 years after a cervical spinal cord injury. |
What this video demonstrates—and what it does not establish
What this video demonstrates
- Sustained, fine-grained 2D trajectory control suitable for freehand illustration rather than just coarse grid clicking.
- Longitudinal home usability across months of participation in the PRIME study.
Scope limits & what it does not establish
- Qualitative participant vignette; pair with quantitative BPS metrics in the Summer/Fall 2025 updates.
How this fits into Neuralink's broader clinical and hardware roadmap
This video sits inside the Movement & computer control (Telepathy) research track on StonkBuilder's independent Neuralink hub. All Neuralink hardware (the N1 implant and R1 surgical robot) and clinical programs (PRIME NCT06429735, CONVOY, and VOICE NCT07224256) remain investigational and have not received FDA commercial marketing authorization. Read our full companion guide at Movement & computer control (Telepathy) for cohort context.
Sources checked 30 Oct 2026
Sources and official records
- [1] Neuralink YouTube (2026-08-26): Neuralnauts | Audrey ↗ · Verified 30 Oct 2026
- [2] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) ↗ · Verified 30 Oct 2026
- [3] Neuralink: Official website and investigational device notice ↗ · Verified 30 Oct 2026
- [4] Neuralink: Clinical Trials and Patient Registry ↗ · Verified 30 Oct 2026
- [5] ClinicalTrials.gov: The PRIME Study (NCT06429735) ↗ · Verified 30 Oct 2026
- [6] Neuralink: Two Years of Telepathy (28 Jan 2026) ↗ · Verified 30 Oct 2026